Views & Analysis | Perspectives on pharma industry issues

Digital

Two female silhouettes in a city office overlook the urban landscape below

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Articles

Media perspectives: Rob Wright

Rob Wright, from Life Science Leader magazine, shares his unique perspective working within the media industry, after spending more than 17 years working in pharmaceuticals. Once a month we bring you a unique perspective on the media industry – this month it’s the turn of Rob Wright, Chief Editor...

Articles

How much confidence can we place in clinical evidence?

Is it so important to reach a 5 sigma level of significance with research findings? Robert Matthews thinks it is and explains the implications on how confident we can be in clinical data if only a 2 sigma level of significance is achieved. Robert Matthews is Visiting Reader in Science at Aston University, Birmingham. He currently focuses on using techniques...

Articles

Rare diseases: overcoming barriers in R&D

As our rare disease themed month continues, we interview Peter L. Saltonstall, CEO of National Organization for Rare Disorders (NORD). Rare diseases present many barriers to pharmaceutical research and product development. Peter L. Saltonstall...

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access